PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Feb-2025 ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051 ENA Respiratory
10-Feb-2025 Santhera Announces Chief Financial Officer Transition with Appointment of Catherine Isted Santhera Pharmaceuticals
10-Feb-2025 Uniphar Expands Global Footprint with Three New Facilities in the USA, Netherlands and Ireland Uniphar
10-Feb-2025 KITE PRESENTS NEW DATA ON PATIENT OUTCOMES WITH CAR T-CELL THERAPY AT THE 7TH EUROPEAN CAR T-CELL MEETING, 6-8 FEBRUARY, STRASBOURG, FRANCE Kite
10-Feb-2025 Industry/academia links fuel UK medical innovation Association of the British Pharmaceutical Industry (ABPI)
07-Feb-2025 Gerresheimer AG confirms discussions with private equity investors on potential takeover offer Gerresheimer AG
07-Feb-2025 Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting Sartorius Stedim Biotech SA
07-Feb-2025 New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis Roche
07-Feb-2025 AI makes medical history as world’s first autonomous skin cancer detection system is approved for clinical decisions in Europe Skin Analytics
07-Feb-2025 Dermaliq Strengthens Scientific & Medical Advisory Board with Renowned Hair Research Expert Ralf Paus MD, DSc, FRSB to Advance Alopecia Drug Development Dermaliq
07-Feb-2025 Epitopea Appoints Klaus Edvardsen M.D., Ph.D. as Chief Medical Officer Epitopea
07-Feb-2025 Execution of a share buyback agreement for up to €2 billion Sanofi
07-Feb-2025 Pioneer appoints Chris Walters to drive European expansion Pioneer Group
07-Feb-2025 Clinigen and Essential Pharma Expand Collaboration to Improve Patient Access in JAPAC Clinigen
07-Feb-2025 Actimed Therapeutics Expands Intellectual Property Portfolio Actimed Therapeutics
07-Feb-2025 Third Quarter Update Syncona Limited
07-Feb-2025 Accumulus Synergy Powers Industry’s First Digitally Generated Dossier to Nearly Two Dozen Countries Simultaneously Accumulus Synergy
06-Feb-2025 DOUGLAS: Conference call on the results for the 1st quarter 2024/2025 (ending 31 December 2024) on 13 February 2025 Douglas AG
06-Feb-2025 Vita 34 AG strengthens its international brand presence by change of name to FamiCord AG Vita 34 AG
06-Feb-2025 BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 BioVersys AG